Allan Meldgaard Lund

Medicine & Life Sciences

1. Neonatal Screening 100%
2. Denmark 83%
3. Mutation 68%
4. Glutaric Acidemia I 64%
5. Mucopolysaccharidosis II 59%
6. Osteogenesis Imperfecta 52%
7. Marfan Syndrome 50%
8. Systemic carnitine deficiency 44%
9. glutaconic acid 39%
10. acylcarnitine 39%
11. 2-hydroxyglutarate dehydrogenase 39%
12. Miller-McKusick-Malvaux-Syndrome (3M Syndrome) 38%
13. Trimethylaminuria 36%
14. Glutaryl-CoA Dehydrogenase 36%
15. Isovaleric acidemia 35%
16. Carnitine 35%
17. Newborn Infant 33%
18. Genes 32%
19. Phenotype 32%
20. Mucopolysaccharidosis I 32%
21. Medium chain acyl CoA dehydrogenase deficiency 32%
22. Mucopolysaccharidosis III 31%
23. Cystinosis 30%
24. Receptor, Fibroblast Growth Factor, Type 3 30%
25. Metachromatic Leukodystrophy 29%
26. Greenland 29%
27. Cysteamine 28%
28. Growth Charts 28%
29. Nuchal Translucency Measurement 27%
30. Dermatan Sulfate 27%
31. Protein-Restricted Diet 25%
32. Disaccharides 25%
33. N-acetylaspartate 25%
34. Alleles 25%
35. Heparitin Sulfate 24%
36. Inborn Errors Metabolism 23%
37. hydroxide ion 22%
38. Ligases 21%
39. Odorants 20%
40. Physiologic Monitoring 20%
41. Transferases 20%
42. Leucine 20%
43. N-Methyl-D-Aspartate Receptors 19%
44. Rare Diseases 19%
45. Kidney Transplantation 18%
46. Fertility 18%
47. Inborn Genetic Diseases 18%
48. Fatty Acids 18%
49. Fishes 18%
50. 2-Hydroxyglutaricaciduria 17%